WCM Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-674,195
Closed -$8.62M 109
2015
Q3
$8.62M Sell
674,195
-133,380
-17% -$1.66M 0.21% 57
2015
Q2
$8.94M Buy
807,575
+256,175
+46% +$2.83M 0.2% 72
2015
Q1
$6.3M Buy
551,400
+137,980
+33% +$1.46M 0.13% 93
2014
Q4
$4.17M Buy
413,420
+98,090
+31% +$1.03M 0.12% 86
2014
Q3
$3.31M Buy
315,330
+5,450
+2% +$51.2K 0.1% 83
2014
Q2
$2.67M Buy
309,880
+45,510
+17% +$383K 0.07% 102
2014
Q1
$2.32M Buy
264,370
+238,375
+917% +$2.07M 0.08% 101
2013
Q4
$213K Buy
+25,995
New +$206K 0.01% 130

Other funds holding RDY

WCM Investment Management's RDY Position: Q4 2015 in Review

WCM Investment Management sold out of Dr. Reddy's Laboratories (RDY) in Q4 2015, closing a stake of 674,195 shares — an estimated $8.62M sold.

WCM Investment Management first reported a position in RDY in Q4 2013 and held it in 8 quarters. The position peaked at $8.94M in Q2 2015. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2015.

  • WCM Investment Management reported no remaining Dr. Reddy's Laboratories position as of Q4 2015 after selling out during the quarter.
  • WCM Investment Management sold 674,195 Dr. Reddy's Laboratories shares in Q4 2015, an estimated $8.62M.
  • WCM Investment Management first reported a position in Dr. Reddy's Laboratories in Q4 2013 and held it in 8 quarters.
  • WCM Investment Management's Dr. Reddy's Laboratories position peaked at $8.94M in Q2 2015.
  • 174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2015.

Based on WCM Investment Management's 13F filing for Q4 2015, filed 10 Feb 2016.